← Leaderboards
David Coen
Beth Israel Deaconess Medical Center
$2,147,531
Attributed
$2,147,531
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $471.6K · FY2006–10$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$2,147,531 · 1
By mechanism
P01$2,147,531 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- James Burton Whitney$8,899,901
- Timothy Vartanian$10,867,825
- Cornelis P Terhorst$22,963,281
- Bjorn R Olsen$23,352,119
- Thomas M Schultheiss$2,512,389
Others in their field
Top investigators on “Drug Delivery Systems”
- Wafaa M. El-Sadr · Columbia University Health Sciences$101,800,876
- Myron S Cohen · Family Health International$101,800,876
- Gerald Van Belle · University Of Washington$48,120,734
- David Heimbrook · Leidos Biomedical Research, Inc.$47,325,954
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$38,382,452
- Martin Friedlander · Scripps Research Institute$36,319,942
Research focus
Drug Delivery SystemsAcyclovirDna BiosynthesisAntiviral AgentsAllelesBacterial Artificial ChromosomesBaseAffectBiologicalBiologyAuthorization DocumentationCell LineCell NucleusCell TypeChinese PeopleChromatinBehaviorAntigen PresentationCodeCollaborationsCultured CellsDetectionDisclosureDrug Resistance
Grant awards (5)
HSV Drug Targets, Gene Expression, and Latency$471,611
P01 · FY2010 · NS · contact PI
HSV Drug Targets, Gene Expression, and Latency$462,964
P01 · FY2009 · NS · contact PI
HSV Drug Targets, Gene Expression, and Latency$453,890
P01 · FY2008 · NS · contact PI
HSV Drug Targets, Gene Expression, and Latency$345,356
P01 · FY2007 · NS · contact PI
HSV Drug Targets, Gene Expression, and Latency$413,710
P01 · FY2006 · NS · contact PI